Squarepoint’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,230
| Closed | -$1.49M | – | 2739 |
|
|
2022
Q2 | $1.49M | Sell |
10,230
-1,443
| -12% | -$210K | 0.01% | 875 |
|
|
2022
Q1 | $1.38M | Buy |
+11,673
| New | +$1.38M | 0.01% | 981 |
|
|
2021
Q4 | – | Sell |
-12,927
| Closed | -$1.8M | – | 2995 |
|
|
2021
Q3 | $1.8M | Buy |
12,927
+7,486
| +138% | +$1.04M | 0.01% | 832 |
|
|
2021
Q2 | $528K | Buy |
+5,441
| New | +$528K | ﹤0.01% | 1573 |
|
|
2020
Q4 | – | Sell |
-13,774
| Closed | -$895K | – | 3089 |
|
|
2020
Q3 | $895K | Buy |
+13,774
| New | +$895K | 0.01% | 1007 |
|
|
2020
Q2 | – | Sell |
-20,213
| Closed | -$688K | – | 2622 |
|
|
2020
Q1 | $688K | Sell |
20,213
-18,016
| -47% | -$613K | 0.02% | 881 |
|
|
2019
Q4 | $2.08M | Buy |
38,229
+8,917
| +30% | +$485K | 0.01% | 861 |
|
|
2019
Q3 | $1.22M | Sell |
29,312
-31,512
| -52% | -$1.31M | 0.01% | 1065 |
|
|
2019
Q2 | $2.66M | Sell |
60,824
-20,577
| -25% | -$901K | 0.03% | 689 |
|
|
2019
Q1 | $4.19M | Buy |
81,401
+25,800
| +46% | +$1.33M | 0.04% | 509 |
|
|
2018
Q4 | $2.06M | Buy |
55,601
+745
| +1% | +$27.5K | 0.02% | 657 |
|
|
2018
Q3 | $2.06M | Buy |
54,856
+40,256
| +276% | +$1.51M | 0.02% | 719 |
|
|
2018
Q2 | $577K | Buy |
14,600
+4,500
| +45% | +$178K | 0.01% | 1121 |
|
|
2018
Q1 | $260K | Sell |
10,100
-11,465
| -53% | -$295K | ﹤0.01% | 1379 |
|
|
2017
Q4 | $582K | Buy |
+21,565
| New | +$582K | 0.01% | 1106 |
|